Literature DB >> 26433845

The Use of Interferons in the Treatment of Cutaneous T-Cell Lymphoma.

Natalie Spaccarelli1, Alain H Rook2.   

Abstract

Interferons are polypeptides that naturally occur in the human body as a part of the innate immune response. By harnessing these immunomodulatory functions, synthetic interferons have shown efficacy in combating various diseases including cutaneous T-cell lymphoma. This article closely examines the qualities of interferon alfa and interferon gamma and the evidence behind their use in the 2 most common types of cutaneous T-cell lymphomas, namely, mycosis fungoides and Sézary syndrome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cutaneous T-cell lymphoma; Interferon alfa; Interferon gamma; Interferons; Mycosis fungoides; Sézary syndrome

Mesh:

Substances:

Year:  2015        PMID: 26433845     DOI: 10.1016/j.det.2015.05.008

Source DB:  PubMed          Journal:  Dermatol Clin        ISSN: 0733-8635            Impact factor:   3.478


  17 in total

1.  Interventions for mycosis fungoides.

Authors:  Arash Valipour; Manuel Jäger; Peggy Wu; Jochen Schmitt; Charles Bunch; Tobias Weberschock
Journal:  Cochrane Database Syst Rev       Date:  2020-07-07

2.  Profile of differentially expressed Toll-like receptor signaling genes in the natural killer cells of patients with Sézary syndrome.

Authors:  Kelly C G ManfrereC; Marina P Torrealba; Denis R Miyashiro; Nátalli Z Pereira; Fabio S Y Yoshikawa; Luana de M Oliveira; Jade Cury-Martins; Alberto J S Duarte; José A Sanches; Maria N Sato
Journal:  Oncotarget       Date:  2017-09-18

3.  TCR-CXCR4 signaling stabilizes cytokine mRNA transcripts via a PREX1-Rac1 pathway: implications for CTCL.

Authors:  Kimberly N Kremer; Brittney A Dinkel; Rosalie M Sterner; Douglas G Osborne; Dragan Jevremovic; Karen E Hedin
Journal:  Blood       Date:  2017-07-10       Impact factor: 22.113

Review 4.  Improvement of the anticancer efficacy of PD-1/PD-L1 blockade via combination therapy and PD-L1 regulation.

Authors:  Mengling Wu; Qianrui Huang; Yao Xie; Xuyi Wu; Hongbo Ma; Yiwen Zhang; Yong Xia
Journal:  J Hematol Oncol       Date:  2022-03-12       Impact factor: 17.388

Review 5.  How to Sequence Therapies in Mycosis Fungoides.

Authors:  Caitlin M Brumfiel; Meera H Patel; Pranav Puri; Jake Besch-Stokes; Scott Lester; William G Rule; Nandita Khera; Jason C Sluzevich; David J DiCaudo; Nneka Comfere; N Nora Bennani; Allison C Rosenthal; Mark R Pittelkow; Aaron R Mangold
Journal:  Curr Treat Options Oncol       Date:  2021-09-27

6.  Pilot Study of a Novel Therapeutic Approach for Refractory Advanced Stage Folliculotropic Mycosis Fungoides.

Authors:  Christina A Del Guzzo; Neha N Jariwala; Paul L Haun; Kelly M MacArthur; Christen M Mowad; Elisabeth G Richard; Joseph P Holton; Alain H Rook
Journal:  Acta Derm Venereol       Date:  2020-06-18       Impact factor: 3.875

7.  Immunomodulation in Cutaneous T Cell Lymphoma.

Authors:  Martina Ferranti; Giulia Tadiotto Cicogna; Irene Russo; Mauro Alaibac
Journal:  Front Oncol       Date:  2019-10-09       Impact factor: 6.244

Review 8.  Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape.

Authors:  Xianjie Jiang; Jie Wang; Xiangying Deng; Fang Xiong; Junshang Ge; Bo Xiang; Xu Wu; Jian Ma; Ming Zhou; Xiaoling Li; Yong Li; Guiyuan Li; Wei Xiong; Can Guo; Zhaoyang Zeng
Journal:  Mol Cancer       Date:  2019-01-15       Impact factor: 27.401

9.  Low-Dose Intralesional Recombinant Interferon-α2b in the Treatment of Mycosis Fungoides.

Authors:  Jamie Katy Hu; Kacie Carlson; Michael Girardi
Journal:  Yale J Biol Med       Date:  2020-03-27

10.  Real-world data on the effectiveness and safety of interferon-alpha-2a intralesional injection for the treatment of focally recalcitrant mycosis fungoides.

Authors:  Shi-Yu Zhang; Zhao-Rui Liu; Lu Yang; Tao Wang; Jie Liu; Yue-Hua Liu; Kai Fang
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.